Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

NCT00504803 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Liege